Not stated as a therapeutic-area list. The company names immuno-oncology and T-cell biology as biologics/discovery focus areas; its offering is otherwise described by modality (small moleculespeptidesoligonucleotidesmAbs
FDA
SCALE 00 studies
Open to sponsorsSelectiveView Irvine, United States · North America
Not presented as a therapeutic-area list. Company service pages name oncology (PDXCDXorthotopicsyngeneic
SCALE 00 studies
Open to sponsorsGeneral clinicalView Company lists: Oncology & HematologyDermatologyNeuroscienceBiosimilar Development
SCALE 270 studies
Open to sponsorsGeneral clinicalView 
